Able Partners

Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.

Cartwheel is a provider of mental health support specifically designed for the school community, founded in 2022 and based in Cambridge, Massachusetts. The company addresses the growing mental health crisis among students by offering evidence-based services from licensed clinicians. Cartwheel partners with schools to facilitate rapid access to mental health assessments, therapy, and medication evaluations, aiming to empower school staff, alleviate family stress, and enhance overall student mental health outcomes. Its program is compliant with FERPA and HIPAA regulations, ensuring it meets the unique needs of educational institutions in the aftermath of the COVID-19 pandemic. By focusing on creating a supportive environment, Cartwheel helps schools become places where every student can thrive.

Journey Clinical offers an online platform that supports independent psychotherapists in expanding their practices to include ketamine-assisted psychotherapy. The company facilitates prescription services, enabling mental health professionals to provide safe and effective psychedelic therapy to patients.

Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.

Little Otter is a company dedicated to children's mental health. It offers an app that connects families with qualified mental health providers, providing evidence-based advice and guidance tailored to children's needs.

Founded in 2019, Ksana Health specializes in digital mental health solutions. Its platform collects user data related to mental health and facilitates its transfer to healthcare practitioners for improved patient care.

Synthesis Institute B.V. operates a medical psilocybin retreat center based in Amsterdam, the Netherlands. Founded in 2017, the company focuses on providing a comprehensive approach to psychedelic wellness, offering services that include health screenings, coaching, educational workshops, group integration, and accommodation. Synthesis aims to create transformative experiences through professionally administered psilocybin, catering to individuals seeking alternative therapies. Additionally, the organization supports research into the effects of psychedelics, facilitating new modes of study for researchers in a controlled and professional environment. By combining wellness practices with scientific inquiry, Synthesis is at the forefront of the evolving field of psychedelic therapy.

COMPASS Pathways is a UK-based mental health care company dedicated to accelerating patient access to innovative treatments for mental health challenges. The company focuses on developing psilocybin therapy, administered in conjunction with psychological support, for patients with treatment-resistant depression who have not responded to conventional treatments.

Alma is a membership-based network for mental health care providers that aims to improve access to high-quality, affordable mental health care. Its platform enables providers to accept insurance and also provides a member directory, client-matching service, scheduling, and billing functions, as well as education, training, and a community for support.

ATAI Life Sciences is a biotechnology company focused on developing therapies for mental health disorders, leveraging psychedelic compounds and neuroscience-based approaches. It operates a platform for mental health drug discovery and development and collaborates with partners and research institutions to advance its pipeline, which includes VLS-01, a buccal-film DMT candidate for treatment-resistant depression, and EMP-01, an oral MDMA therapy for social anxiety disorder, along with a drug discovery program aimed at identifying non-hallucinogenic 5-HT2A receptor agonists for depression. The company is based in Munich, Germany, with additional offices in Berlin and London.

Alma is a membership-based network for mental health care providers that aims to improve access to high-quality, affordable mental health care. Its platform enables providers to accept insurance and also provides a member directory, client-matching service, scheduling, and billing functions, as well as education, training, and a community for support.